Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			6 Months Ended		43 Months Ended
	Nov. 02, 2023	Aug. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Aug. 31, 2020
Class Of Stock [Line Items]
Maximum amount of sale covered in shelf registration statement						$ 300,000
Proceeds from issuance of shares			$ 0	$ 14,480
Bile Acid Portfolio Acquisition
Class Of Stock [Line Items]
Shares issued, public offering price per share (in dollars per share)		$ 26.25
Net proceeds from transaction		$ 202,200
Leerink Partners LLC
Class Of Stock [Line Items]
Maximum amount of offering issuance and sale covered in sales agreement						$ 75,000
Sales Agreement
Class Of Stock [Line Items]
Net proceeds from transaction	$ 200,000
Percentage of gross proceeds	3.00%
Common Stock | Sales Agreement
Class Of Stock [Line Items]
Number of shares issued (in shares)					2,125,090
Gross proceeds from issuance of common stock					$ 43,700
Private Placement | Bile Acid Portfolio Acquisition
Class Of Stock [Line Items]
Number of shares issued (in shares)		8,000,000